HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015

Julia M.L. Brotherton, Karen L. Winch, Genevieve Chappell, Carolyn Banks, Dennis Meijer, Sonya Ennis, Karen Peterson, Rosalind Webby, Lisa J. Whop

    Research output: Contribution to journalArticleResearchpeer-review

    Abstract

    Objective: To estimate human papillomavirus (HPV) vaccination coverage and course completion rates for Indigenous adolescents in four Australian states and territories.

    Participants, setting: Adolescents who were 12 years old in 2015 and received the quadrivalent HPV vaccine (three doses: 0, 2, 6 months) as part of the National HPV Vaccination Program in 2015 or 2016 in New South Wales, Queensland, the Northern Territory, or the Australian Capital Territory.

    Main outcome measures: Estimated HPV vaccination coverage by dose and by Indigenous status and sex, based on National HPV Vaccination Program Register data; vaccination course completion rates (proportion of dose 1 recipients who received dose 3) for 12-year-olds vaccinated during 2013–2016, by sex, jurisdiction, and Indigenous status.

    Results: Dose 1 coverage exceeded 80% for all Indigenous status/jurisdiction/sex groups (range, 83.3–97.7%). Coverage was similar for Indigenous and non-Indigenous girls in Queensland (87.3% v 87.0%), lower for Indigenous girls in the ACT (88.7% v 97.7%) and the NT (91.1% v 97.0%), and higher in NSW (95.9% v 89.9%); it was similar for Indigenous and non-Indigenous boys in all jurisdictions except the NT (88.6% v 96.3%). Dose 3 coverage (range, 61.2–87.7%) was markedly lower for Indigenous than non-Indigenous 12-year-olds in all jurisdictions, except for girls in NSW (82.6% v 83.6%).

    Conclusion: HPV vaccine coverage is high, but course completion is generally lower for Indigenous adolescents. Strategies for improving completion rates for Indigenous Australians are needed to end the higher burden of cervical cancer among Indigenous than non-Indigenous women.

    Original languageEnglish
    Pages (from-to)31-36
    Number of pages6
    JournalMedical Journal of Australia
    Volume211
    Issue number1
    Early online date9 Jun 2019
    DOIs
    Publication statusPublished - Jul 2019

    Fingerprint

    Vaccination
    Papillomavirus Vaccines
    Queensland
    Australian Capital Territory
    Northern Territory
    New South Wales
    Uterine Cervical Neoplasms
    Outcome Assessment (Health Care)

    Cite this

    Brotherton, Julia M.L. ; Winch, Karen L. ; Chappell, Genevieve ; Banks, Carolyn ; Meijer, Dennis ; Ennis, Sonya ; Peterson, Karen ; Webby, Rosalind ; Whop, Lisa J. / HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015. In: Medical Journal of Australia. 2019 ; Vol. 211, No. 1. pp. 31-36.
    @article{d79871f04e314aa2a850adc59fe14190,
    title = "HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015",
    abstract = "Objective: To estimate human papillomavirus (HPV) vaccination coverage and course completion rates for Indigenous adolescents in four Australian states and territories. Participants, setting: Adolescents who were 12 years old in 2015 and received the quadrivalent HPV vaccine (three doses: 0, 2, 6 months) as part of the National HPV Vaccination Program in 2015 or 2016 in New South Wales, Queensland, the Northern Territory, or the Australian Capital Territory. Main outcome measures: Estimated HPV vaccination coverage by dose and by Indigenous status and sex, based on National HPV Vaccination Program Register data; vaccination course completion rates (proportion of dose 1 recipients who received dose 3) for 12-year-olds vaccinated during 2013–2016, by sex, jurisdiction, and Indigenous status. Results: Dose 1 coverage exceeded 80{\%} for all Indigenous status/jurisdiction/sex groups (range, 83.3–97.7{\%}). Coverage was similar for Indigenous and non-Indigenous girls in Queensland (87.3{\%} v 87.0{\%}), lower for Indigenous girls in the ACT (88.7{\%} v 97.7{\%}) and the NT (91.1{\%} v 97.0{\%}), and higher in NSW (95.9{\%} v 89.9{\%}); it was similar for Indigenous and non-Indigenous boys in all jurisdictions except the NT (88.6{\%} v 96.3{\%}). Dose 3 coverage (range, 61.2–87.7{\%}) was markedly lower for Indigenous than non-Indigenous 12-year-olds in all jurisdictions, except for girls in NSW (82.6{\%} v 83.6{\%}). Conclusion: HPV vaccine coverage is high, but course completion is generally lower for Indigenous adolescents. Strategies for improving completion rates for Indigenous Australians are needed to end the higher burden of cervical cancer among Indigenous than non-Indigenous women.",
    keywords = "Papillomavirus infections, Uterine cervical neoplasms, Vaccination",
    author = "Brotherton, {Julia M.L.} and Winch, {Karen L.} and Genevieve Chappell and Carolyn Banks and Dennis Meijer and Sonya Ennis and Karen Peterson and Rosalind Webby and Whop, {Lisa J.}",
    year = "2019",
    month = "7",
    doi = "10.5694/mja2.50221",
    language = "English",
    volume = "211",
    pages = "31--36",
    journal = "Medical Journal of Australia",
    issn = "0025-729X",
    publisher = "Australasian Medical Publishing Company",
    number = "1",

    }

    Brotherton, JML, Winch, KL, Chappell, G, Banks, C, Meijer, D, Ennis, S, Peterson, K, Webby, R & Whop, LJ 2019, 'HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015', Medical Journal of Australia, vol. 211, no. 1, pp. 31-36. https://doi.org/10.5694/mja2.50221

    HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015. / Brotherton, Julia M.L.; Winch, Karen L.; Chappell, Genevieve; Banks, Carolyn; Meijer, Dennis; Ennis, Sonya; Peterson, Karen; Webby, Rosalind; Whop, Lisa J.

    In: Medical Journal of Australia, Vol. 211, No. 1, 07.2019, p. 31-36.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015

    AU - Brotherton, Julia M.L.

    AU - Winch, Karen L.

    AU - Chappell, Genevieve

    AU - Banks, Carolyn

    AU - Meijer, Dennis

    AU - Ennis, Sonya

    AU - Peterson, Karen

    AU - Webby, Rosalind

    AU - Whop, Lisa J.

    PY - 2019/7

    Y1 - 2019/7

    N2 - Objective: To estimate human papillomavirus (HPV) vaccination coverage and course completion rates for Indigenous adolescents in four Australian states and territories. Participants, setting: Adolescents who were 12 years old in 2015 and received the quadrivalent HPV vaccine (three doses: 0, 2, 6 months) as part of the National HPV Vaccination Program in 2015 or 2016 in New South Wales, Queensland, the Northern Territory, or the Australian Capital Territory. Main outcome measures: Estimated HPV vaccination coverage by dose and by Indigenous status and sex, based on National HPV Vaccination Program Register data; vaccination course completion rates (proportion of dose 1 recipients who received dose 3) for 12-year-olds vaccinated during 2013–2016, by sex, jurisdiction, and Indigenous status. Results: Dose 1 coverage exceeded 80% for all Indigenous status/jurisdiction/sex groups (range, 83.3–97.7%). Coverage was similar for Indigenous and non-Indigenous girls in Queensland (87.3% v 87.0%), lower for Indigenous girls in the ACT (88.7% v 97.7%) and the NT (91.1% v 97.0%), and higher in NSW (95.9% v 89.9%); it was similar for Indigenous and non-Indigenous boys in all jurisdictions except the NT (88.6% v 96.3%). Dose 3 coverage (range, 61.2–87.7%) was markedly lower for Indigenous than non-Indigenous 12-year-olds in all jurisdictions, except for girls in NSW (82.6% v 83.6%). Conclusion: HPV vaccine coverage is high, but course completion is generally lower for Indigenous adolescents. Strategies for improving completion rates for Indigenous Australians are needed to end the higher burden of cervical cancer among Indigenous than non-Indigenous women.

    AB - Objective: To estimate human papillomavirus (HPV) vaccination coverage and course completion rates for Indigenous adolescents in four Australian states and territories. Participants, setting: Adolescents who were 12 years old in 2015 and received the quadrivalent HPV vaccine (three doses: 0, 2, 6 months) as part of the National HPV Vaccination Program in 2015 or 2016 in New South Wales, Queensland, the Northern Territory, or the Australian Capital Territory. Main outcome measures: Estimated HPV vaccination coverage by dose and by Indigenous status and sex, based on National HPV Vaccination Program Register data; vaccination course completion rates (proportion of dose 1 recipients who received dose 3) for 12-year-olds vaccinated during 2013–2016, by sex, jurisdiction, and Indigenous status. Results: Dose 1 coverage exceeded 80% for all Indigenous status/jurisdiction/sex groups (range, 83.3–97.7%). Coverage was similar for Indigenous and non-Indigenous girls in Queensland (87.3% v 87.0%), lower for Indigenous girls in the ACT (88.7% v 97.7%) and the NT (91.1% v 97.0%), and higher in NSW (95.9% v 89.9%); it was similar for Indigenous and non-Indigenous boys in all jurisdictions except the NT (88.6% v 96.3%). Dose 3 coverage (range, 61.2–87.7%) was markedly lower for Indigenous than non-Indigenous 12-year-olds in all jurisdictions, except for girls in NSW (82.6% v 83.6%). Conclusion: HPV vaccine coverage is high, but course completion is generally lower for Indigenous adolescents. Strategies for improving completion rates for Indigenous Australians are needed to end the higher burden of cervical cancer among Indigenous than non-Indigenous women.

    KW - Papillomavirus infections

    KW - Uterine cervical neoplasms

    KW - Vaccination

    UR - http://www.scopus.com/inward/record.url?scp=85067341840&partnerID=8YFLogxK

    U2 - 10.5694/mja2.50221

    DO - 10.5694/mja2.50221

    M3 - Article

    VL - 211

    SP - 31

    EP - 36

    JO - Medical Journal of Australia

    JF - Medical Journal of Australia

    SN - 0025-729X

    IS - 1

    ER -